1Legro RS.Polycystic ovary syndrome:phenotype to genotype[J].Endocrinol Metab Clin North Am,1999,28 (2):379 -396.
2Reaven G.Syndrome X:10 years after[J].Drugs,1999,58(19-20):75-82.
3Kathleen M,Hoeger T.Obesity and lifestyle management in polycystic ovary[J].Clin Obstet Gynecol,2007,50(1):277-294.
4Guzick DS,Wing R,Smith D,et al.Endocrine consequences of weight loss in obese,hyperandrogenic,anovulatory women[J].Fertil Steril,1994,61(4):598-604.
5AI-Azemi M,Omu FE,Omu AE.The effect of obesity on the outcome of infertility management in women with polycystic ovary syndrome[J].Arch Gynecol Obstet,2004,270(4):205-210.
6Jakubowicz DJ,Nestler JE.17 alpha-hydroxyprogesterone response to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome offer dietary weight loss[J].J Clin Endocrinol Metab,1997,82 (2),556-560.
7Trentham-Dietz A,Nichols HB,Hampton JM,et al.Weight change and risk of endometrial cancer[J].Int J Epidemiol,2006,35 (1):151-158.
8Tuomtlehto J.Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance[J].New EngI J Med,2001,344(18):1343-1350.
9Moran LJ,Nakes M,Clifton PM,et al.Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome[J].J Clin Endocrinol Metab,2003,88 (2):812-819.
10National Institutes of Health.Clinical guidelines on the identification,evalution and treatment of overweight and obesity in adults:evidence report[J].Obes Res,1998,6 (2):151-209.
